Hepatitis B OnlineLogo
  • Quick
    Reference

    Quick Reference

    Rapidly access information

    1. HBV Epidemiology

      HBV Epidemiology

      1. Background
      2. HBV Incidence in the United States
      3. HBV Prevalence in the United States
      4. Awareness of HBV Infection Status
      5. Global HBV Epidemiology
      6. Risks Associated with HBV Acquisition
      7. CDC Case Definition and Reporting
      8. HBV Disease Burden and HBV-Related Deaths
      9. Summary Points
    2. HBV Screening, Testing, and Diagnosis

      HBV Screening, Testing, and Diagnosis

      1. HBV Screening Recommendations
      2. Rationale for Universal HBV Screening in Adults
      3. HBV Tests
      4. Recommended Screening Tests
      5. Incorporation of HBV Screening into Clinical Workflows
      6. Evolution of Serologic Tests after Infection and Vaccination
      7. Interpretation of HBV Serologic Tests
      8. Summary Points
    3. HBV Immunizations

      HBV Immunizations

      1. Background
      2. Vaccine Uptake
      3. Indications for Hepatitis B Vaccination
      4. Prevaccination Serologic Testing
      5. HBV Vaccines and Schedules
      6. Response to HBV Vaccines
      7. Postvaccination Serologic Testing
      8. Management of HBV Vaccine Nonresponders
      9. Summary Points
    4. Initial Evaluation of Persons with Chronic Hepatitis B

      Initial Evaluation of Persons with Chronic Hepatitis B

      1. Background
      2. Key Aspects of Medical History
      3. Key Aspects of the Physical Examination
      4. Initial Laboratory Evaluation
      5. Screening for Other Causes of Liver Disease
      6. Evaluation of Fibrosis Stage
      7. Immunizations for Persons with Chronic HBV and Cirrhosis
      8. Counseling Persons with Chronic HBV Following Diagnosis
      9. Summary Points
    5. When to Initiate HBV Treatment

      When to Initiate HBV Treatment

      1. Background
      2. Goals of Therapy with Treatment of Chronic HBV
      3. Factors Used to Determine Whether to Initiate Treatment
      4. Hepatitis B Treatment Guidance Recommendations
      5. Special Indications for Initiating Treatment
      6. Summary Points
    6. Choosing an Initial HBV Treatment Regimen

      Choosing an Initial HBV Treatment Regimen

      1. Background
      2. Oral Antiviral Therapy Options for HBV
      3. Peginterferon-Based Therapy for HBV
      4. Recommendations for Initial HBV Therapy
      5. Summary Points
    7. Monitoring Persons On and Off HBV Therapy

      Monitoring Persons On and Off HBV Therapy

      1. Background
      2. Monitoring Persons with Chronic HBV Who are Not on Treatment
      3. Safety Monitoring in Persons with Chronic HBV on Treatment
      4. Definitions Used for Monitoring Response to Therapy
      5. Monitoring Treatment Response in Persons with Chronic HBV
      6. Overview of Monitoring Persons on Hepatitis B Treatment
      7. Discontinuing Antiviral Therapy Based on Treatment Response
      8. Monitoring after Antiviral Therapy is Stopped
      9. Summary Points
    8. Hepatitis B Reactivation

      Hepatitis B Reactivation

      1. Background
      2. Pathophysiology of HBV Reactivation
      3. Clinical Features of HBV Reactivation
      4. Risk Factors for HBV Reactivation
      5. Assessing Risk for HBV Reactivation
      6. Risk Categories for HBV Reactivation
      7. HBV Screening Prior to Initiation of Immunosuppression
      8. Data on Antiviral Therapy to Prevent HBV Reactivation
      9. Recommendations for HBV Prophylactic Antiviral Therapy
      10. Special Populations to Consider for HBV Reactivation
      11. Summary Points
    9. Screening for Hepatocellular Carcinoma

      Screening for Hepatocellular Carcinoma

      1. Epidemiology of HBV-Associated Hepatocellular Carcinoma (HCC)
      2. Factors that Impact HBV-Associated HCC
      3. Prognosis of Persons Diagnosed with HCC
      4. Benefit of HCC Screening in Persons with HBV
      5. HCC Surveillance Testing Methods
      6. Guidelines for HCC Surveillance
      7. Summary Points
    10. Preventing HBV Perinatal Transmission

      Preventing HBV Perinatal Transmission

      1. Universal Screening for HBV Infection During Pregnancy
      2. Risk of Perinatal HBV Transmission
      3. Route and Timing of Perinatal HBV Transmission
      4. Management of Women with Chronic HBV in Pregnancy
      5. Management of Pregnant Women with Isolated Anti-HBc
      6. Management of Acute HBV in Pregnancy
      7. Safety of Antivirals During Pregnancy
      8. Hepatitis B Flares During Pregnancy and in the Postpartum Period
      9. Management of Neonates Born to HBsAg-Positive Mothers
      10. Breastfeeding in HBsAg-Positive Mothers
      11. Summary Points
    11. Occupational HBV Postexposure Prophylaxis

      Occupational HBV Postexposure Prophylaxis

      1. Background
      2. Risk of HBV with Occupational Exposures
      3. Initial Approach to Postexposure Prophylaxis
      4. Interventions for HBV Occupational Postexposure Prophylaxis
      5. Management of Occupational Exposure to HBV
      6. Monitoring of HCP after Occupational HBV Exposure
      7. Efficacy of Occupational Postexposure Prophylaxis for HBV
      8. Summary Points
  • Self
    Study

    Self Study   Free CNE/CME

    Track your progress and receive CE credit

    1. HBV Epidemiology

      HBV Epidemiology

      1. Background
      2. HBV Incidence in the United States
      3. HBV Prevalence in the United States
      4. Awareness of HBV Infection Status
      5. Global HBV Epidemiology
      6. Risks Associated with HBV Acquisition
      7. CDC Case Definition and Reporting
      8. HBV Disease Burden and HBV-Related Deaths
      9. Summary Points
    2. HBV Screening, Testing, and Diagnosis

      HBV Screening, Testing, and Diagnosis

      1. HBV Screening Recommendations
      2. Rationale for Universal HBV Screening in Adults
      3. HBV Tests
      4. Recommended Screening Tests
      5. Incorporation of HBV Screening into Clinical Workflows
      6. Evolution of Serologic Tests after Infection and Vaccination
      7. Interpretation of HBV Serologic Tests
      8. Summary Points
    3. HBV Immunizations

      HBV Immunizations

      1. Background
      2. Vaccine Uptake
      3. Indications for Hepatitis B Vaccination
      4. Prevaccination Serologic Testing
      5. HBV Vaccines and Schedules
      6. Response to HBV Vaccines
      7. Postvaccination Serologic Testing
      8. Management of HBV Vaccine Nonresponders
      9. Summary Points
    4. Initial Evaluation of Persons with Chronic Hepatitis B

      Initial Evaluation of Persons with Chronic Hepatitis B

      1. Background
      2. Key Aspects of Medical History
      3. Key Aspects of the Physical Examination
      4. Initial Laboratory Evaluation
      5. Screening for Other Causes of Liver Disease
      6. Evaluation of Fibrosis Stage
      7. Immunizations for Persons with Chronic HBV and Cirrhosis
      8. Counseling Persons with Chronic HBV Following Diagnosis
      9. Summary Points
    5. When to Initiate HBV Treatment

      When to Initiate HBV Treatment

      1. Background
      2. Goals of Therapy with Treatment of Chronic HBV
      3. Factors Used to Determine Whether to Initiate Treatment
      4. Hepatitis B Treatment Guidance Recommendations
      5. Special Indications for Initiating Treatment
      6. Summary Points
    6. Choosing an Initial HBV Treatment Regimen

      Choosing an Initial HBV Treatment Regimen

      1. Background
      2. Oral Antiviral Therapy Options for HBV
      3. Peginterferon-Based Therapy for HBV
      4. Recommendations for Initial HBV Therapy
      5. Summary Points
    7. Monitoring Persons On and Off HBV Therapy

      Monitoring Persons On and Off HBV Therapy

      1. Background
      2. Monitoring Persons with Chronic HBV Who are Not on Treatment
      3. Safety Monitoring in Persons with Chronic HBV on Treatment
      4. Definitions Used for Monitoring Response to Therapy
      5. Monitoring Treatment Response in Persons with Chronic HBV
      6. Overview of Monitoring Persons on Hepatitis B Treatment
      7. Discontinuing Antiviral Therapy Based on Treatment Response
      8. Monitoring after Antiviral Therapy is Stopped
      9. Summary Points
    8. Hepatitis B Reactivation

      Hepatitis B Reactivation

      1. Background
      2. Pathophysiology of HBV Reactivation
      3. Clinical Features of HBV Reactivation
      4. Risk Factors for HBV Reactivation
      5. Assessing Risk for HBV Reactivation
      6. Risk Categories for HBV Reactivation
      7. HBV Screening Prior to Initiation of Immunosuppression
      8. Data on Antiviral Therapy to Prevent HBV Reactivation
      9. Recommendations for HBV Prophylactic Antiviral Therapy
      10. Special Populations to Consider for HBV Reactivation
      11. Summary Points
    9. Screening for Hepatocellular Carcinoma

      Screening for Hepatocellular Carcinoma

      1. Epidemiology of HBV-Associated Hepatocellular Carcinoma (HCC)
      2. Factors that Impact HBV-Associated HCC
      3. Prognosis of Persons Diagnosed with HCC
      4. Benefit of HCC Screening in Persons with HBV
      5. HCC Surveillance Testing Methods
      6. Guidelines for HCC Surveillance
      7. Summary Points
    10. Preventing HBV Perinatal Transmission

      Preventing HBV Perinatal Transmission

      1. Universal Screening for HBV Infection During Pregnancy
      2. Risk of Perinatal HBV Transmission
      3. Route and Timing of Perinatal HBV Transmission
      4. Management of Women with Chronic HBV in Pregnancy
      5. Management of Pregnant Women with Isolated Anti-HBc
      6. Management of Acute HBV in Pregnancy
      7. Safety of Antivirals During Pregnancy
      8. Hepatitis B Flares During Pregnancy and in the Postpartum Period
      9. Management of Neonates Born to HBsAg-Positive Mothers
      10. Breastfeeding in HBsAg-Positive Mothers
      11. Summary Points
    11. Occupational HBV Postexposure Prophylaxis

      Occupational HBV Postexposure Prophylaxis

      1. Background
      2. Risk of HBV with Occupational Exposures
      3. Initial Approach to Postexposure Prophylaxis
      4. Interventions for HBV Occupational Postexposure Prophylaxis
      5. Management of Occupational Exposure to HBV
      6. Monitoring of HCP after Occupational HBV Exposure
      7. Efficacy of Occupational Postexposure Prophylaxis for HBV
      8. Summary Points
  • HBV Primary
    Care Guidance
  • HBV
    Medications

    1. Oral Antivirals

      • Adefovir
      • Tenofovir DF
      • Tenofovir alafenamide
      • Entecavir
      • Lamivudine
    2. Immune Modulators

      • Peginterferon alfa-2a
      • Interferon alfa-2b
    3. Vaccines

      • Engerix-B
      • Twinrix
      • Recombivax-HB
      • Heplisav-B
  • Tools &
    Calculators

    1. Clinical Calculators

      • AST to Platelet Ratio Index (APRI) Calculator
      • Body Mass Index (BMI) Calculator
      • Child-Turcotte-Pugh (CTP) Calculator
      • Creatinine Clearance (CrCl) Calculator
      • Fibrosis-4 (FIB-4) Calculator
      • 2021 CKD-EPI Adult eGFR Calculator
      • Glasgow Coma Scale (GCS)
      • Model For End-Stage Liver Disease (MELD) for ages 12 and older
      • PAGE-B Risk Score
      • Serum-Ascites Albumin Gradient (SAAG) Calculator
    2. Substance Use Screening Tools

      • CAGE Alcohol Questionnaire
      • Alcohol Use Disorders Identification Test (AUDIT-C)
  • Clinical
    Challenges
  • Mini-
    Lectures
  • Search